Abortion Surveillance — United States, 2018
Surveillance Summaries / November 27, 2020 / 69(7);1–29
Please note: This report has been corrected. To view the errata, please click here and here.
Katherine Kortsmit, PhD1,2; Tara C. Jatlaoui, MD1; Michele G. Mandel1; Jennifer A. Reeves, MD1; Titilope Oduyebo, MD1; Emily Petersen, MD1; Maura K. Whiteman, PhD1 (View author affiliations)
View suggested citationAbstract
Problem/Condition: CDC conducts abortion surveillance to document the number and characteristics of women obtaining legal induced abortions and number of abortion-related deaths in the United States.
Period Covered: 2018.
Description of System: Each year, CDC requests abortion data from the central health agencies for 50 states, the District of Columbia, and New York City. For 2018, 49 reporting areas voluntarily provided aggregate abortion data to CDC. Of these, 48 reporting areas provided data each year during 2009–2018. Census and natality data were used to calculate abortion rates (number of abortions per 1,000 women aged 15–44 years) and ratios (number of abortions per 1,000 live births), respectively. Abortion-related deaths from 2017 were assessed as part of CDC’s Pregnancy Mortality Surveillance System (PMSS).
Results: A total of 619,591 abortions for 2018 were reported to CDC from 49 reporting areas. Among 48 reporting areas with data each year during 2009–2018, in 2018, a total of 614,820 abortions were reported, the abortion rate was 11.3 abortions per 1,000 women aged 15–44 years, and the abortion ratio was 189 abortions per 1,000 live births. From 2017 to 2018, the total number of abortions and abortion rate increased 1% (from 609,095 total abortions and from 11.2 abortions per 1,000 women aged 15–44 years, respectively), and the abortion ratio increased 2% (from 185 abortions per 1,000 live births). From 2009 to 2018, the total number of reported abortions, abortion rate, and abortion ratio decreased 22% (from 786,621), 24% (from 14.9 abortions per 1,000 women aged 15–44 years), and 16% (from 224 abortions per 1,000 live births), respectively.
In 2018, women in their 20s accounted for more than half of abortions (57.7%). In 2018 and during 2009–2018, women aged 20–24 and 25–29 years accounted for the highest percentages of abortions; in 2018, they accounted for 28.3% and 29.4% of abortions, respectively, and had the highest abortion rates (19.1 and 18.5 per 1,000 women aged 20–24 and 25–29 years, respectively). By contrast, adolescents aged <15 years and women aged ≥40 years accounted for the lowest percentages of abortions (0.2% and 3.6%, respectively) and had the lowest abortion rates (0.4 and 2.6 per 1,000 women aged <15 and ≥40 years, respectively). However, abortion ratios in 2018 and throughout 2009–2018 were highest among adolescents (aged ≤19 years) and lowest among women aged 25–39 years. Abortion rates decreased from 2009 to 2018 for all women, regardless of age. The decrease in abortion rate was highest among adolescents compared with women in any other age group. From 2009 to 2013, the abortion rates decreased for all age groups and from 2014 to 2018, the abortion rates decreased for all age groups, except for women aged 30–34 years and those aged ≥40 years. In addition, from 2017 to 2018, abortion rates did not change or decreased among women aged ≤24 and ≥40 years; however, the abortion rate increased among women aged 25–39 years. Abortion ratios also decreased from 2009 to 2018 among all women, except adolescents aged 13 weeks’ gestation remained consistently low (≤9.0%). In 2018, the highest proportion of abortions were performed by surgical abortion at ≤13 weeks’ gestation (52.1%), followed by early medical abortion at ≤9 weeks’ gestation (38.6%), surgical abortion at >13 weeks’ gestation (7.8%), and medical abortion at >9 weeks’ gestation (1.4%); all other methods were uncommon (<0.1%). Among those that were eligible (≤9 weeks’ gestation), 50.0% of abortions were early medical abortions. In 2017, the most recent year for which PMSS data were reviewed for pregnancy-related deaths, two women were identified to have died as a result of complications from legal induced abortion.
Interpretation: Among the 48 areas that reported data continuously during 2009–2018, decreases were observed during 2009–2017 in the total number, rate, and ratio of reported abortions, and these decreases resulted in historic lows for this period for all three measures. These decreases were followed by 1%–2% increases across all measures from 2017 to 2018.
Public Health Action: The data in this report can help program planners and policymakers identify groups of women with the highest rates of abortion. Unintended pregnancy is a major contributor to induced abortion. Increasing access to and use of effective contraception can reduce unintended pregnancies and further reduce the number of abortions performed in the United States.
Introduction
This report summarizes data on legal induced abortions for 2018 that were provided voluntarily to CDC by the central health agencies of 49 reporting areas (47 states, the District of Columbia, and New York City, excluding California, Maryland, and New Hampshire) and comparisons over time for the 48 reporting areas that reported each year during 2009–2018 (47 states and New York City). A summary of data for the 49 reporting areas that provided data voluntarily to CDC for 2017 is available (Supplementary Tables; https://stacks.cdc.gov/view/cdc/96608). This report also summarizes abortion-related deaths reported voluntarily to CDC for 2017 as part of the Pregnancy Mortality Surveillance System (PMSS).
Since 1969, CDC has conducted abortion surveillance to document the number and characteristics of women obtaining legal induced abortions in the United States (1). After nationwide legalization of abortion in 1973, the total number, rate (number of abortions per 1,000 women aged 15–44 years), and ratio (number of abortions per 1,000 live births) of reported abortions increased rapidly, reaching the highest levels in the 1980s, before decreasing at a slow yet steady pace (2–4). During 2006–2008, a break occurred in the previously sustained pattern of decrease (5–8), although this break has been followed in subsequent years by even greater decreases (9–19). Nonetheless, throughout the years, abortion incidence continues to vary across subpopulations (20–26). Continued surveillance is needed to monitor changes in abortion incidence in the United States.
Methods
Description of the Surveillance System
Each year, CDC requests aggregated data from the central health agencies of the 50 states, the District of Columbia, and New York City to document the number and characteristics of women obtaining legal induced abortions in the United States. This report contains data voluntarily reported to CDC as of February 29, 2020. For the purpose of surveillance, a legal induced abortion* is defined as an intervention performed within the limits of state law by a licensed clinician (e.g., a physician, nurse-midwife, nurse practitioner, or physician assistant) intended to terminate a suspected or known intrauterine pregnancy and that does not result in a live birth.
In most states and jurisdictions, collection of abortion data is facilitated by a legal requirement for hospitals, facilities, and physicians to report abortions to a central health agency (27); however, reporting is not complete in all areas, including in some areas with reporting requirements (28). Central health agencies voluntarily report aggregate abortion data to CDC. Because the reporting of abortion data to CDC is voluntary, many reporting areas have developed their own data collection forms and therefore do not collect or provide all of the information requested by CDC. As a result, the level of detail reported by CDC on the characteristics of women obtaining abortions varies from year to year and by reporting area (18). To encourage uniform collection of data, CDC has collaborated with the National Association for Public Health Statistics and Information Systems to develop reporting standards and provide technical guidance for vital statistics personnel who collect and summarize abortion data within the United States.
Variables and Categorization of Data
Each year, CDC sends a suggested template to central health agencies in the United States for compilation of aggregated abortion data. Aggregate abortion numbers, without individual-level records, are requested for the following variables:
- Age group in years of women obtaining legal induced abortions (<15, 15–19 by individual year, 20–24, 25–29, 30–34, 35–39, or ≥40)
- Gestational age of pregnancy in completed weeks at the time of abortion (≤6, 7–20 by individual week, or ≥21)
- Race (Black, White, or other [including Asian, Pacific Islander, other races, and multiple races]), ethnicity (Hispanic or non-Hispanic), and race by ethnicity
- Method type (surgical abortion,† intrauterine instillation, medical [nonsurgical] abortion, or hysterectomy/hysterotomy)
- Marital status (married [including currently married or separated] or unmarried [including never married, widowed, or divorced])
- Number of previous live births (0, 1, 2, 3, or ≥4)
- Number of previous induced abortions (0, 1, 2, or ≥3)
- Residence (the state, jurisdiction, territory, or foreign country in which the woman obtaining the abortion lived, or, if additional details are unavailable, in-reporting area versus out-of-reporting area)
In addition, the template provided by CDC requests that aggregate numbers for certain variables be cross-tabulated by a second variable. The cross-tabulations presented in this report include weeks of gestation separately by method type, by women’s age group, and by race/ethnicity.
Beginning with 2014 data, instead of reporting clinician’s estimates of gestational age or estimates of gestational age based on last menstrual period, some areas have reported “probable postfertilization age,” “clinician’s estimate of gestation based on date of conception,” and “probable gestational age” to CDC. To make data reported as postfertilization age consistent with data collection practices for gestational age recommended by CDC’s National Center for Health Statistics (29), 2 weeks were added to probable postfertilization age. This method was used to account for time after last menstrual period until ovulation in a standard 28-day cycle because fertilization occurs around the time of ovulation (30). No modifications were made to data reported as clinician’s estimate of gestation based on date of conception or data reported as probable gestational age.
In this report, medical and surgical abortions are further categorized by gestational age when available. Early medical abortion is defined as the administration of medications (typically mifepristone followed by misoprostol) to induce an abortion at ≤9 completed weeks’ gestation,§ consistent with the current Food and Drug Administration (FDA) labeling for mifepristone (implemented in 2016) (31). Medications (typically serial prostaglandins, sometimes administered after mifepristone) may also be used to induce an abortion at >9 weeks’ gestation. Surgical abortions are categorized as having been performed at ≤13 weeks’ gestation or at >13 weeks’ gestation because of differences in surgical technique at these gestational ages (32). Finally, because intrauterine instillations cannot be performed early in gestation, abortions reported to have been performed by intrauterine instillation at ≤12 weeks’ gestation are excluded from calculation of the percentage of abortions by known method type and are grouped with unknown type.¶
Measures of Abortion
Four measures of abortion are presented in this report: 1) the number of abortions in a given population, 2) the percentage of abortions among women by selected characteristics, 3) the abortion rate (number of abortions per 1,000 women within a given population), and 4) the abortion ratio (number of abortions per 1,000 live births within a given population). Abortion rates adjust for differences in population size. Abortion ratios measure the relative number of pregnancies in a population that end in abortion compared with live birth.
U.S. Census Bureau estimates of the resident female population were used as the denominator for calculating abortion rates (33–42). Overall abortion rates were calculated from the population of women aged 15–44 years living in the reporting areas that provided data. For adolescents aged <15 years, abortion rates were calculated using the number of adolescents aged 13–14 years; for women aged ≥40 years, abortion rates were calculated using the number of women aged 40–44 years. For the calculation of abortion ratios, live birth data were obtained from CDC natality files and included births to women of all ages living in the reporting areas that provided abortion data (43–45). For calculation of the total abortion rates and total ratios only, women with unknown data on selected characteristics (e.g., age, race/ethnicity, and marital status) were distributed according to the distribution of abortions among women with known information on the characteristic. For calculation of totals only, abortions for women with an unknown gestational age of pregnancy but known method type were distributed according to the distribution of abortions among women with known information on method type by gestational age to the following categories: surgical, ≤13 weeks’ gestation; surgical, >13 weeks’ gestation; medical, ≤9 weeks’ gestation; and medical, >9 weeks’ gestation.
Data Presentation and Analysis
This report provides aggregate and reporting area–specific abortion numbers, rates, and ratios for the 49 areas that reported to CDC for 2018, which excluded California, Maryland, and New Hampshire. In addition, this report describes characteristics of women who obtained abortions in 2018. The data in this report are presented by the reporting area in which the abortions were performed. Overall abortion rates and ratios are not presented for reporting areas with <20 total reported abortions because calculations are considered statistically unstable (46). Wyoming, which reported <20 abortions, was only included in total abortions overall and was excluded from all subsequent analyses.
The completeness and quality of data received varies by year and by variable; this report only describes the characteristics of women obtaining abortions in reporting areas that met CDC reporting standards (i.e., reported at least 20 abortions overall, provided data categorized in accordance with requested variables, and had <15% unknown values for a given characteristic). Cells with a value in the range of 1–4 or cells that would allow for calculation of these values have been suppressed in this report to maintain confidentiality.
Trends in the number, rate, and ratio of reported abortions and annual data are presented for the 48 areas that reported data every year during 2009–2018. The percentage change in abortion measures from the most recent past year (2017 to 2018) and during the 10-year period of analysis (2009 to 2018) were calculated for these 48 reporting areas.
Trends were also reported for abortions by age group of women obtaining abortions and by weeks of gestation. Annual data are presented for areas that met reporting standards every year during 2009–2018; the percentage change was calculated from the beginning to the end of the 10-year period of analysis (2009–2018), from the beginning to the end of the first and second halves of this period (2009–2013 and 2014–2018), and from the most recent past year (2017 to 2018). Consistent with previous reports, key findings for trends are presented to highlight observed changes over time and differences between groups. However, no statistical testing was performed. Comparisons do not imply statistical significance, and lack of comment regarding the difference between values does not imply that no statistically significant difference exists.
To calculate trends for early medical abortions (≤9 completed weeks’ gestation), areas were included if they met reporting standards and if they specifically included medical abortion as a method on their reporting form for the years needed for 10-year, 5-year, and 1-year percentage change calculations (2009 to 2018, 2009 to 2013, 2014 to 2018, and 2017 to 2018). These data are reported to monitor any changes in clinical practice that might have occurred with the accumulation of evidence on the safety and effectiveness of medical abortion past 63 days of gestation (≤8 completed weeks) (47), changes in professional practice guidelines published in 2013 and 2014 (48,49), and the 2016 FDA extension of the gestational age limit for the use of mifepristone for early medical abortion from 63 days to 70 days (≤9 completed weeks’ gestation) (50).
Data from some reporting areas are not included in trends if the data did not meet reporting standards every year during 2009–2018 (for overall, age, and gestational age trend analyses) or if data did not meet reporting standards for selected years of comparison (for early medical abortion trend analysis). As a result, aggregate measures for 2018 in trend analyses might differ from the point estimates reported for 2018.
Abortion Mortality
CDC has reported data on abortion-related deaths periodically since information on abortion mortality first was included in the 1972 abortion surveillance report (18,51). An abortion-related death is defined as a death resulting from a direct complication of an abortion (legal or illegal), an indirect complication caused by a chain of events initiated by an abortion, or an aggravation of a preexisting condition by the physiologic or psychologic effects of abortion (52). An abortion is categorized as legal when it is performed by a licensed clinician within the limits of state law.
Since 1987, CDC has monitored abortion-related deaths through PMSS (53,54). Sources of data to identify abortion-related deaths have included state vital records; media reports, including computerized searches of full-text newspaper and other print media databases; and individual case reports by public health agencies, including maternal mortality review committees, health care providers and provider organizations, private citizens, and citizen groups. For each death that is possibly related to abortion, CDC requests clinical records and autopsy reports. Two medical epidemiologists independently review these reports to determine the cause of death and whether the death was abortion related. Discrepancies are discussed and resolved by consensus. Each death is categorized by abortion type as legal induced, illegal induced, spontaneous, or unknown type.
This report provides PMSS data on induced abortion-related deaths that occurred in 2017, the most recent year for which PMSS data are available. Data on induced abortion-related deaths that occurred during 1972–2015 have been published (12–15,17,18,54). For 1998–2017, abortion surveillance data reported to CDC cannot be used alone to calculate national legal induced abortion case-fatality rates (number of legal induced abortion-related deaths per 100,000 reported legal induced abortions in the United States) because eight states** did not report abortion data every year during this period. Thus, denominator data for calculation of national legal induced abortion case-fatality rates were obtained from a published report by the Guttmacher Institute that includes estimated total numbers of abortions in the United States from a national survey of abortion-providing facilities (19). Because rates determined on the basis of a numerator of <20 deaths are unstable (46), national legal induced abortion case-fatality rates were calculated for consecutive 5-year periods during 1973–2017.
Results
Total Abortions Reported to CDC by Occurrence
Among the 49 reporting areas that provided data for 2018, a total of 619,591 abortions were reported. Of these abortions, 614,820 (99.2%) were from 48 reporting areas that provided data every year for 2009–2018. In 2018, these continuously reporting areas had an abortion rate of 11.3 abortions per 1,000 women aged 15–44 years and an abortion ratio of 189 abortions per 1,000 live births (Table 1). In 2017, the total number, rate, and ratio of reported abortions decreased to historic lows for the period of analysis for all three measures. From 2017 to 2018, the total number of reported abortions and abortion rate increased 1% (from 609,095 to 614,820 total abortions and from 11.2 to 11.3 abortions per 1,000 women aged 15–44 years), and the abortion ratio increased 2% (from 185 to 189 abortions per 1,000 live births). From 2009 to 2018, the total number of reported abortions decreased 22% (from 786,621), the abortion rate decreased 24% (from 14.9 abortions per 1,000 women aged 15–44 years), and the abortion ratio decreased 16% (from 224 abortions per 1,000 live births) (Figure).
In 2018, a considerable range existed in abortion rates by reporting area of occurrence (from 2.4 to 26.8 abortions per 1,000 women aged 15–44 years in South Dakota and New York City) and abortion ratios (from 32 to 518 abortions per 1,000 live births in South Dakota and the District of Columbia)†† (Table 2). The percentage of abortions obtained by out-of-state residents also varied among reporting areas (from 0.4% in Arizona to 65.4% in the District of Columbia). Overall, start highlight0.9%end highlight of abortions were reported to CDC with unknown residence.
Age Group, Race/Ethnicity, and Marital Status
Among the 48 areas that reported abortion numbers by women’s age for 2018, women in their 20s accounted for the majority (57.7%) of abortions and had the highest abortion rates (19.1 and 18.5 abortions per 1,000 women aged 20–24 and 25–29 years, respectively) (Table 3). Women in the youngest (<15 years) and oldest (≥40 years) age groups accounted for the smallest percentages of abortions (0.2% and 3.6%, respectively) and had the lowest abortion rates (0.4 and 2.6 abortions per 1,000 women aged <15 and ≥40 years, respectively). In contrast, abortion ratios in 2018 were lowest among women aged 25–39 years (126–189 per 1,000 live births).
Among the 44 reporting areas that provided data each year by women’s age for 2009–2018, this pattern across age groups was stable, with the majority of abortions and the highest abortion rates occurring among women aged 20–29 years and the lowest percentages of abortions and abortion rates occurring among women in the youngest and oldest age groups (Table 4). From 2009 to 2018, abortion rates decreased among all age groups, although the decreases for adolescents (64% and 55% for adolescents aged <15 and 15–19 years, respectively) were greater than the decreases for women in all older age groups. From 2009 to 2013, the abortion rates decreased for all age groups, and from 2014 to 2018, the abortion rates decreased for all age groups except women aged 30–34 years and ≥40 years. From 2017 to 2018, abortion rates did not change or decreased among women aged ≤24 and ≥40 years; however, the abortion rate increased among women aged 25–39 years. During 2009–2018, abortion ratios decreased among women in all age groups, except for adolescents aged <15 years. The abortion ratio decreased for all age groups from 2009 to 2013; however, from 2014 to 2018, abortion ratios only decreased for women aged ≥35 years. From 2017 to 2018, abortion ratios increased for all age groups, except women aged ≥40 years.
Among the 46 areas§§ that reported women’s age by individual year among adolescents for 2018, adolescents aged 18–19 years accounted for the majority (69.7%) of adolescent abortions and had the highest adolescent abortion rates (8.6 and 12.2 abortions per 1,000 adolescents aged 18 and 19 years, respectively). Adolescents aged <15 years accounted for the smallest percentage of adolescent abortions (2.5%) and had the lowest adolescent abortion rate (0.4 abortions per 1,000 adolescents aged 13–14 years). In 2018, the abortion ratio for adolescents was highest among adolescents aged <15 years (833 abortions per 1,000 live births) and was lowest among adolescents aged ≥17 years (336, 346, and 284 abortions per 1,000 live births among adolescents aged 17, 18, and 19 years, respectively).
Among the 31 areas that reported race/ethnicity data for 2018, non-Hispanic White women and non-Hispanic Black women accounted for the largest percentages of all abortions (38.7% and 33.6%, respectively), and Hispanic women and non-Hispanic women in the other race category accounted for smaller percentages (20.0% and 7.7%, respectively) (Table 5). Non-Hispanic White women had the lowest abortion rate (6.3 abortions per 1,000 women) and ratio (110 abortions per 1,000 live births), and non-Hispanic Black women had the highest abortion rate (21.2 abortions per 1,000 women) and ratio (335 abortions per 1,000 live births).
Among the 42 areas that reported by marital status for 2018, 14.8% of women who obtained an abortion were married, and 85.2% were unmarried (Table 6). The abortion ratio was 44 abortions per 1,000 live births for married women and 378 abortions per 1,000 live births for unmarried women.
Previous Live Births and Abortions
Data from the 43 areas that reported the number of previous live births for women who obtained abortions in 2018 indicate that 40.7%, 24.8%, 19.8%, and 14.7% of these women had zero, one, two, or three or more previous live births, respectively (Table 7). Data from the 40 areas that reported the number of previous abortions for women who obtained abortions in 2018 indicate that the majority (59.9%) had previously had no abortions, 23.9% had previously had one abortion, 9.9% had previously had two abortions, and 6.4% had previously had three or more abortions (Table 8).
Weeks of Gestation and Method Type
Among the 42 areas that reported gestational age¶¶ at the time of abortion for 2018, approximately three fourths (77.7%) of abortions were performed at ≤9 weeks’ gestation, and nearly all (92.2%) were performed at ≤13 weeks’ gestation (Table 9). Fewer abortions were performed at 14–20 weeks’ gestation (6.9%) or at ≥21 weeks’ gestation (1.0%). Among the 34 reporting areas that provided data every year on gestational age for 2009–2018, the percentage of abortions performed at ≤13 weeks’ gestation changed negligibly, from 91.8% to 91.5% (Table 10). However, within this gestational age range, a shift occurred toward earlier gestational ages, with the percentage of abortions performed at ≤6 weeks’ gestation increasing 8% and the percentage of abortions performed at 7–9 weeks’ and 10–13 weeks’ gestation decreasing 2% and 14%, respectively. During 2009–2018, abortions performed at >13 weeks’ gestation accounted for ≤9.0% of abortions. Among the 45 areas that reported by method type for 2018 and included medical abortion on their reporting form, 52.1% of abortions were surgical abortions at ≤13 weeks’ gestation, 38.6% were early medical abortions (a nonsurgical abortion at ≤9 weeks’ gestation), 7.8% were surgical abortions at >13 weeks’ gestation, and 1.4% were medical abortions at >9 weeks’ gestation; other methods, including intrauterine instillation and hysterectomy/hysterotomy, were both uncommon (<0.1%) (Table 11). Among the 37 reporting areas*** that included medical abortion on their reporting form and provided these data for the relevant years of comparison, use of early medical abortion increased 9% from 2017 to 2018 (from 34.7% of abortions to 37.7%) and 120% from 2009 to 2018 (from 17.1% of abortions to 37.7%). Increases in early medical abortion occurred both from 2009 to 2013 (from 17.1% of abortions to 22.7% [33% increase]) and from 2014 to 2018 (from 23.3% of abortions to 37.7% [62% increase]).
Among the 40 areas that reported abortions categorized by individual weeks of gestation and method type, surgical abortion accounted for the largest percentage of abortions within every gestational age category, except ≤6 weeks’ gestation (Table 12). At ≤6 weeks’ gestation, surgical abortion accounted for 45.1% of abortions. Surgical abortion accounted for 55.3% of abortions at 7–9 weeks’ gestation, 93.8%–98.4% of abortions at 10–20 weeks’ gestation, and 91.9% of abortions at ≥21 weeks’ gestation. In contrast, medical abortion accounted for 54.9% of abortions at ≤6 weeks’ gestation, 44.7% of abortions at 7–9 weeks’ gestation, 6.2% of abortions at 10–13 weeks’ gestation, 1.5%–3.2% of abortions at 14–20 weeks’ gestation, and 7.2% of abortions at ≥21 weeks’ gestation. For each gestational age category (if applicable), abortions performed by intrauterine instillation or hysterectomy/hysterotomy were rare (<0.1%–0.8% of abortions).
Weeks of Gestation by Age Group and Race/Ethnicity
In selected reporting areas, abortions that were categorized by weeks of gestation were further categorized by age and race/ethnicity (Table 13). In every subgroup for these characteristics, the largest percentage of abortions occurred at ≤9 weeks’ gestation. In 42 reporting areas, by age, 55.1% of adolescents aged <15 years and 71.5% of adolescents aged 15–19 years obtained an abortion at ≤9 weeks’ gestation, compared with ≥76.8% among age groups aged ≥20 years. Conversely, 21.7% of adolescents aged <15 years and 10.3% of adolescents aged 15–19 years obtained an abortion after 13 weeks’ gestation, compared with 7.3%–8.0% for women in older age groups. In 30 reporting areas, by race/ethnicity, 73.3% of non-Hispanic Black women obtained an abortion at ≤9 weeks’ gestation, compared with 79.6%–81.5% of women from other racial/ethnic groups. Differences in abortions after 13 weeks’ gestation across race/ethnicity were minimal (8.8% for non-Hispanic Black women, compared with 6.5%–8.1% for women in the remaining racial/ethnic groups).
Abortion Mortality
Using national PMSS data (53), CDC identified two abortion-related deaths for 2017, the most recent year for which data were reviewed for abortion-related deaths (Table 14). Investigation of these cases indicated that two deaths were related to legal abortion.
The annual number of deaths related to legal induced abortion has fluctuated from year to year since 1973 (Table 14). Because of this variability and the relatively limited number of deaths related to legal induced abortions every year, national legal abortion case-fatality rates were calculated for consecutive 5-year periods during 1973–2017. The national legal induced abortion case-fatality rate for 2013–2017 was 0.44 legal induced abortion-related deaths per 100,000 reported legal abortions. This case-fatality rate was lower than the rates for the preceding 5-year periods.
Discussion
For 2018, a total of 619,591 abortions were reported to CDC by 49 areas. Of these reporting areas, 48 submitted data every year for 2009–2018, thus providing the information necessary for consistently reporting trends. Among these 48 areas, for 2018, the abortion rate was 11.3 abortions per 1,000 women aged 15–44 years, and the abortion ratio was 189 abortions per 1,000 live births. Although the rate of reported abortions declined overall from 2009 to 2018, from 2017 to 2018, the number and rate of reported abortions increased 1%, and the abortion ratio increased 2%.
Among areas that reported data continuously by age from 2009 to 2018, women in their 20s accounted for the majority of abortions and had the highest abortion rates, whereas adolescents aged ≤19 years had the lowest abortion rates. During 2009–2018, women aged ≥40 years accounted for a relatively small proportion of reported abortions (≤3.7%). However, the abortion ratio among women aged ≥40 years continues to be higher than among women aged 25–39 years. These data underscore important age differences in abortion measures.
The adolescent abortion trends described in this report are important for monitoring progress that has been made toward reducing adolescent pregnancies in the United States. From 2009 to 2018, national birth data indicate that the birth rate for adolescents aged 15–19 years decreased 54% (44,55), and the data in this report indicate that the abortion rate for the same age group decreased 55%. These findings highlight that decreases in adolescent births in the United States have been accompanied by large decreases in adolescent abortions (44,55).
As in previous years, abortion rates and ratios differ across racial/ethnic groups. For example, in 2018, compared with non-Hispanic White women, abortion rates and ratios were 3.4 and 3.0 times higher among non-Hispanic Black women and 1.7 and 1.4 times higher among Hispanic women. Similar differences have been demonstrated in other U.S.-based research (3,4,20–26,56). The comparatively higher abortion rates and ratios among non-Hispanic Black women have been attributed to higher unintended pregnancy rates and a greater percentage of unintended pregnancies ending in abortion in this group (57). The complex factors contributing to differences to ensure equitable access to quality family planning services need to be identified (58,59).
In 2018, the majority of abortions occurred early in gestation (≤9 weeks), when the risks for complications are lowest (60–63). In addition, over the last 10 years, approximately three fourths of abortions were performed at ≤9 weeks’ gestation, and this percentage increased from 74.2% in 2009 to 76.2% in 2018. Moreover, among the areas that reported abortions at ≤13 weeks’ gestation by individual week, the distribution of abortions by gestational age continued to shift toward earlier weeks of gestation, with the percentage of early abortions performed at ≤6 weeks’ gestation increasing from 33.6% in 2009 to 36.2% in 2018.
From 2009 to 2018, the percentage of abortions performed at >13 weeks’ gestation did not change appreciably, remaining at ≤9.0%. Previous research indicates that the distribution of abortions by gestational age differs by various sociodemographic characteristics (64–66). In this report, the percentage of adolescents aged ≤19 years who obtained abortions at >13 weeks’ gestation was higher than the percentage of women in older age groups who obtained abortions. Multiple factors might influence the gestational age when abortions are performed (56,60–63,65–69).
The trend of obtaining abortions earlier in pregnancy has been facilitated by changes in abortion practices. Research conducted in the United States during the 1970s indicated that surgical abortion procedures performed at ≤6 weeks’ gestation, compared with 7–12 weeks’ gestation, were less likely to result in successful termination of the pregnancy (70). However, subsequent advances in technology (e.g., improved transvaginal ultrasonography and sensitivity of pregnancy tests) have allowed very early surgical abortions to be performed with completion rates exceeding 97% (71–74). Likewise, the development of early medical abortion regimens has allowed for abortions to be performed early in gestation, with completion rates for regimens that combine mifepristone and misoprostol reaching 96%–98% (74–77). In 2018, 77.7% of all reported abortions were ≤9 weeks’ gestation thus were eligible for early medical abortion; of these, 50.0% were reported as medical abortions. Moreover, among areas that included medical abortion on their reporting form, the percentage of all abortions performed by early medical abortion increased 120% from 2009 to 2018.
Because the annual number of deaths related to legal induced abortion is small and statistically unstable, case-fatality rates were calculated for consecutive 5-year periods during 1973–2017. The national legal induced abortion case-fatality rate for 2013–2017 was fewer than 1 per 100,000 abortions, as it was for all the previous 5-year periods since the late 1970s, demonstrating the low risk for death associated with legal induced abortion.
Limitations
The findings in this report are subject to at least four limitations. First, because reporting to CDC is voluntary and reporting requirements vary by the individual reporting areas (28), CDC is unable to report the total number of abortions performed in the United States. Of the 52 areas from which CDC requested data for 2018, California, Maryland, and New Hampshire did not submit abortion data. In 2017, the most recent year for which data are available through the Guttmacher Institute’s national survey of abortion-providing facilities, abortions performed in California, Maryland, and New Hampshire accounted for approximately 19% of all abortions in the United States (19). In addition, the District of Columbia and New Jersey did not have abortion reporting requirements to a centralized health agency during the period covered in this report (27), which potentially affects the representativeness of data these jurisdictions send to CDC. Moreover, even in states that legally require clinicians to submit a report for every abortion they perform, enforcement of this requirement varies.††† The accuracy of comparative data reported by the Guttmacher Institute is affected by facility response rates, the accuracy of information reported by facilities, as well as the degree to which abortion counts were estimated from nonfacility data sources (19).
Second, many states use abortion reporting forms that differ from the technical guidance that CDC developed in collaboration with the National Association for Public Health Statistics and Information Systems. Consequently, multiple reporting areas do not collect all variables requested by CDC (e.g., age and race/ethnicity) or do not report the data in a manner consistent with this guidance (e.g., gestational age). Missing demographic information can reduce the extent to which the statistics in this report represent women who have had abortions. Findings in this report on demographic characteristics of women seeking abortions were generally similar to previously published data from Guttmacher Institute’s national survey of abortion patients in 2014, although the percentage of abortions accounted for by non-Hispanic Black women was start highlightlowerend highlight and by Hispanic women was start highlighthigherend highlight as compared with data provided to CDC (25). Differences are likely attributable to the fact that race/ethnicity data that met CDC’s reporting standards were only reported to CDC by 31 reporting areas. Some areas that either do not report to CDC (e.g., California) or do not report race/ethnicity data (e.g., Illinois) have sufficiently large populations of minority women that the absence of data from these areas likely reduces the representativeness of CDC data for these variables. In addition, some areas collect gestational age data that are based on estimated date of conception or probable postfertilization age, which are not consistent with medical conventions for gestational age reporting. Without medical guidance on how to report these data, the validity and reliability of gestational age for these reporting areas is uncertain.
Third, abortion data are compiled and reported to CDC by the central health agency of the reporting area in which the abortion was performed rather than the reporting area in which the woman lived. Thus, the available population (33–42) and birth data (43–45), which are organized by the states in which women live, might differ from the population of women who undergo abortions in a given reporting area. This likely results in an overestimation of abortions for reporting areas in which a higher percentage of abortions are obtained by out-of-state residents and an underestimation of abortions for states where residents more frequently obtain abortions out of state. Limited abortion services, stringent regulatory requirements for obtaining an abortion, or geographic proximity to services in another state might influence where women obtain abortion services (78).
Finally, CDC reporting of sociodemographic characteristics of women obtaining abortions is limited to data collected on jurisdiction reporting forms. Therefore, examining additional demographic variables, (e.g., socioeconomic status) is not possible.
Public Health Implications
Ongoing surveillance of legal induced abortion is important for several reasons. First, abortion surveillance can be used to help evaluate programs aimed at preventing unintended pregnancies. Although pregnancy intentions can be difficult to assess (79–84), abortion surveillance provides an important indicator of unintended pregnancies because up to 42% of unintended pregnancies in the United States end in abortion (57). Efforts to help women avoid unintended pregnancies might reduce the number of abortions (85,86). Second, routine abortion surveillance is needed to assess trends in clinical practice patterns over time. Information in this report on the number of abortions performed through different methods (e.g., medical or surgical) and at different gestational ages provides the denominator data that are necessary for analyses of the relative safety of abortion practices (54). Finally, information on the number of pregnancies ending in abortion is needed in conjunction with data on births and fetal losses to estimate the number of pregnancies in the United States and determine rates for various outcomes of public health importance (e.g., adolescent pregnancies) (87).
Approximately 18% of all pregnancies in the United States end in induced abortion (19). Multiple factors influence the incidence of abortion, including access to health care services and contraception (85,86,88,89); the availability of abortion providers (8,11,16,90–93); state regulations, such as mandatory waiting periods (69,94,95), parental involvement laws (96,97), and legal restrictions on abortion providers (98–102); increasing acceptance of nonmarital childbearing (103,104); and changes in the economy and the resulting impact on fertility and contraceptive use (105).
The most recent data available indicate that the proportion of pregnancies in the United States that were unintended decreased from 51% in 2008 to 45% during 2011–2013 (57). Changing patterns of contraception use might have contributed to this decrease in unintended pregnancy. Use of long-acting reversible contraception (LARC) (i.e., intrauterine devices and hormonal implants), which are the most effective reversible contraceptive methods, has recently increased among all women (106–109), and the use of contraception overall appears to be increasing among sexually active adolescents (110). In addition, immediate postpartum and postabortion contraception provision, especially of LARC, has been shown to decrease rapid repeat pregnancy and repeat abortions (111–117). Further, providing contraception for women at low or no cost can increase use of more effective contraceptive methods for pregnancy prevention and reduce unintended pregnancy and abortion rates (85,86,88,118–120). Inadequate provider reimbursement and training, insufficient client-centered counseling, lack of youth-friendly services, and low client awareness of available contraceptive methods are reported barriers to accessing contraception (121–124). Reducing these barriers might help improve access to contraception and potentially reduce the number of unintended pregnancies and the number of abortions in the United States.
Corresponding author: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC. E-mail: cdcinfo@cdc.gov.
1Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC; 2Oak Ridge Institute for Science and Education
Conflicts of Interest
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
* Hereafter, all abortions in this report are considered to be legally induced unless stated otherwise.
† Includes dilation and curettage (aspiration curettage, suction curettage, manual vacuum aspiration, menstrual extraction, and sharp curettage) and dilation and evacuation procedures.
§ CDC collects information only on the estimated number of weeks (not days) of gestation and acknowledges the conventional use of completed weeks of gestation to describe pregnancy duration. CDC’s category ≤9 weeks’ gestation thus includes abortions up through 9 weeks and 6 days.
¶ The cutoff of ≤12 weeks was selected on the basis of the implausibility of this procedure being performed at earlier gestational ages.
** States that did not report for ≥1 year from 1998 to 2017 include Alaska (1998–2000), California (1998–2017), District of Columbia (2016), Louisiana (2005), Maryland (2007–2017), New Hampshire (1998–2017), Oklahoma (1998–1999), and West Virginia (2003–2004).
†† Comparisons do not include Wyoming, which reported <20 abortions and therefore was excluded from this and all subsequent analyses.
§§ Excludes California, Connecticut, Illinois, Maryland, New Hampshire, and Wyoming.
¶¶ Arkansas, South Carolina, and Texas collected probable postfertilization age. Two weeks were added to the probable postfertilization age to provide a corresponding measure to gestational age based on the clinician’s estimate. Virginia reported clinician’s estimate of gestational age based on conception; no modifications were made to these data.
*** Excludes Alabama, California, Delaware, Florida, Hawaii, Illinois, Louisiana, Maryland, Nevada, New Hampshire, New Mexico, Tennessee, Vermont, Wisconsin, and Wyoming
††† For 2018, data that Wyoming reported to CDC were <5% of the estimated abortions reported by the Guttmacher Institute through their 2017 national survey of abortion-providing facilities, the most recent year for which the Guttmacher Institute has published data. CDC 2018 numbers for Colorado, Connecticut, District of Columbia, Hawaii, Iowa, Louisiana, Missouri, New Jersey, New Mexico, New York (city and state combined), Rhode Island, and South Dakota were 48%–85% of the Guttmacher Institute 2017 estimates. All other areas that provided data to CDC for 2018 were ≥90% of Guttmacher Institute 2017 estimates.
References
- Smith JC. Abortion surveillance report, hospital abortions, annual summary 1969. Atlanta, GA: US Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration, National Communicable Disease Center; 1970.
- Gamble SB, Strauss LT, Parker WY, Cook DA, Zane SB, Hamdan S. Abortion surveillance—United States, 2005. MMWR Surveill Summ 2008;57(No. SS-13). PubMed
- Henshaw SK, Kost K. Trends in the characteristics of women obtaining abortions, 1974 to 2004. New York, NY: Guttmacher Institute; 2008. https://www.guttmacher.org/report/trends-characteristics-women-obtaining-abortions-1974-2004-supplemental-tables
- Jones RK, Kost K, Singh S, Henshaw SK, Finer LB. Trends in abortion in the United States. Clin Obstet Gynecol 2009;52:119–29. CrossRef PubMed
- Pazol K, Gamble SB, Parker WY, Cook DA, Zane SB, Hamdan S. Abortion surveillance—United States, 2006. MMWR Surveill Summ 2009;58(No. SS-8). PubMed
- Pazol K, Zane S, Parker WY, et al. . Abortion surveillance—United States, 2007. MMWR Surveill Summ 2011;60(No. SS-1). PubMed
- Pazol K, Zane SB, Parker WY, Hall LR, Berg C, Cook DA. Abortion surveillance—United States, 2008. MMWR Surveill Summ 2011;60(No. SS-15). PubMed
- Jones RK, Kooistra K. Abortion incidence and access to services in the United States, 2008. Perspect Sex Reprod Health 2011;43:41–50. CrossRef PubMed
- Pazol K, Creanga AA, Zane SB, Burley KD, Jamieson DJ. Abortion surveillance—United States, 2009. MMWR Surveill Summ 2012;61(No. SS-8). PubMed
- Pazol K, Creanga AA, Burley KD, Hayes B, Jamieson DJ. Abortion surveillance—United States, 2010. MMWR Surveill Summ 2013;62(No. SS-8). PubMed
- Jones RK, Jerman J. Abortion incidence and service availability in the United States, 2011. Perspect Sex Reprod Health 2014;46:3–14. CrossRef PubMed
- Pazol K, Creanga AA, Burley KD, Jamieson DJ. Abortion surveillance—United States, 2011. MMWR Surveill Summ 2014;63(No. SS-11). PubMed
- Pazol K, Creanga AA, Jamieson DJ. Abortion surveillance—United States, 2012. MMWR Surveill Summ 2015;64(No. SS-10). CrossRef PubMed
- Jatlaoui TC, Ewing A, Mandel MG, et al. Abortion surveillance—United States, 2013. MMWR Surveill Summ 2016;65(No. SS-12). CrossRef PubMed
- Jatlaoui TC, Shah J, Mandel MG, et al. Abortion surveillance—United States, 2014. MMWR Surveill Summ 2017;66(No. SS-24). CrossRef PubMed
- Jones RK, Jerman J. Abortion incidence and service availability in the United States, 2014. Perspect Sex Reprod Health 2017;49:17–27. CrossRef PubMed
- Jatlaoui TC, Boutot ME, Mandel MG, et al. Abortion surveillance—United States, 2015. MMWR Surveill Summ 2018;67(No. SS-13). CrossRef PubMed
- Jatlaoui TC, Eckhaus L, Mandel MG, et al. Abortion surveillance—United States, 2016. MMWR Surveill Summ 2019;68(No. SS-11). CrossRef PubMed
- Jones RK, Witwer E, Jerman J. Abortion incidence and service availability in the United States, 2017. New York, NY: Guttmacher Institute; 2019. https://www.guttmacher.org/report/abortion-incidence-service-availability-us-2017
- Henshaw SK, Silverman J. The characteristics and prior contraceptive use of U.S. abortion patients. Fam Plann Perspect 1988;20:158–68. CrossRef PubMed
- Henshaw SK, Kost K. Abortion patients in 1994–1995: characteristics and contraceptive use. Fam Plann Perspect 1996;28:140–7, 158. PubMed
- Jones RK, Darroch JE, Henshaw SK. Patterns in the socioeconomic characteristics of women obtaining abortions in 2000–2001. Perspect Sex Reprod Health 2002;34:226–35. CrossRef PubMed
- Jones RK, Finer LB, Singh S. Characteristics of U.S. abortion patients, 2008. New York, NY: Guttmacher Institute; 2010. https://www.guttmacher.org/report/characteristics-us-abortion-patients-2008
- Jones RK, Kavanaugh ML. Changes in abortion rates between 2000 and 2008 and lifetime incidence of abortion. Obstet Gynecol 2011;117:1358–66. CrossRef PubMed
- Jerman J, Jones RK, Onda T. Characteristics of U.S. abortion patients in 2014 and changes since 2008. New York, NY: Guttmacher Institute; 2016. https://www.guttmacher.org/sites/default/files/report_pdf/characteristics-us-abortion-patients-2014.pdf
- Jones RK, Jerman J. Population group abortion rates and lifetime incidence of abortion: United States, 2008–2014. Am J Public Health 2017;107:1904–9. CrossRef PubMed
- Guttmacher Institute. Abortion reporting requirements. New York, NY: Guttmacher Institute; 2020. https://www.guttmacher.org/state-policy/explore/abortion-reporting-requirements
- Saul R. Abortion reporting in the United States: an examination of the federal-state partnership. Fam Plann Perspect 1998;30:244–7. CrossRef PubMed
- CDC. Guide to completing the facility worksheets for the certificate of live birth and report of fetal death. Hyattsville, MD: CDC, National Center for Health Statistics; 2016. https://www.cdc.gov/nchs/data/dvs/GuidetoCompleteFacilityWks.pdf
- Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility: Philadelphia, PA: Wolters Kluwer Health; 2012.
- Mifeprex (mifepristone) [Package Insert]. New York, NY, Danco Laboratories; 2016.
- Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD. Management of unintended and abnormal pregnancy: comprehensive abortion care. Oxford, England: Blackwell Publishing Ltd.; 2009.
- CDC. July 1, 2000–July 2009 revised bridged-race intercensal population estimates. [File icen_2000_09_y06sas.zip]. Hyattsville, MD: CDC, National Center for Health Statistics; 2012. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#july2009
- CDC. July 1, 2000–July 2009 revised bridged-race intercensal population estimates. [File icen_2000_09_y07.sas.zip]. Hyattsville, MD: CDC, National Center for Health Statistics; 2012. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#july2009
- CDC. July 1, 2000–July 2009 revised bridged-race intercensal population estimates. [File icen_2000_09_y08.sas.zip]. Hyattsville, MD: CDC, National Center for Health Statistics; 2012. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#july2009
- CDC. July 1, 2000–July 2009 revised bridged-race intercensal population estimates. [File icen_2000_09_y09.sas.zip]. Hyattsville, MD: CDC, National Center for Health Statistics; 2012. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#july2009
- CDC. Bridged-race population estimates, April 1, 2010. [File census_0401_2010.sas7bdat.zip]. Hyattsville, MD: CDC, National Center for Health Statistics; 2011. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#april2010
- CDC. Postcensal estimates of the resident population of the United States as of July 1, 2011, by year, state and county, age, bridged race, sex, and Hispanic origin (Vintage 2011). [File pcen_v2011_y11.sasbdat]. Hyattsville, MD: CDC, National Center for Health Statistics; 2012. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2011
- CDC. Postcensal estimates of the resident population of the United States as of July 1, 2012, by year, state and county, age, bridged race, sex, and Hispanic origin (Vintage 2012) [File pcen_v2012_y12.sasbdat]. Hyattsville, MD: CDC, National Center for Health Statistics; 2013. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2012
- CDC. Postcensal estimates of the resident population of the United States as of July 1, 2013, by year, state and county, age, bridged race, sex, and Hispanic origin (Vintage 2013) [File pcen_v2013_y13.sasbdat]. Hyattsville, MD: CDC, National Center for Health Statistics; 2014. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2013
- CDC. Postcensal estimates of the resident population of the United States as of July 1, 2014, by year, state and county, age, bridged race, sex, and Hispanic origin (Vintage 2014) [File pcen_v2014_y14.sasbdat]. Hyattsville, MD: CDC, National Center for Health Statistics; 2015. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2014
- CDC. Postcensal estimates of the resident population of the United States as of July 1, 2015, by year, state and county, age, bridged race, sex, and Hispanic origin (Vintage 2015). [File pcen_v2015_y15.sasbdat]. Hyattsville, MD: CDC, National Center for Health Statistics; 2016. https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2015
- CDC. Natality files. Hyattsville, MD: CDC, National Center for Health Statistics. https://wonder.cdc.gov/Natality.html
- Martin JA, Hamilton BE, Osterman MJK. Births in the United States, 2018. NCHS Data Brief 2019;346:1–8. PubMed
- Martin JA, Hamilton BE, Osterman MJK. Births in the United States, 2017. NCHS Data Brief 2018;318:1–8. PubMed
- Hoyert DL. Maternal mortality and related concepts. Vital Health Stat 3 2007;(33):1–13. PubMed
- Winikoff B, Dzuba IG, Chong E, et al. Extending outpatient medical abortion services through 70 days of gestational age. Obstet Gynecol 2012;120:1070–6. CrossRef PubMed
- National Abortion Federation. 2013 clinical policy guidelines. Washington, DC: National Abortion Federation; 2013. http://prochoice.org/pubs_research/publications/documents/2013NAFCPGsforweb.pdf
- Creinin M, Grossman DA. Medical management of first-trimester abortion. Contraception 2014;89:148–61. CrossRef PubMed
- Food and Drug Administration. Mifeprex (mifepristone) information. Silver Spring, MD: Food and Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/mifeprex-mifepristone-information
- CDC. Abortion surveillance, 1972. Atlanta, GA: US Department of Health, Education, and Welfare, Public Health Service; CDC; 1974.
- CDC. Abortion surveillance, 1977. Atlanta, GA: US Department of Health, Education, and Welfare, Public Health Service, CDC; 1979.
- CDC. Pregnancy mortality surveillance in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm
- Zane S, Creanga AA, Berg CJ, et al. Abortion-related mortality in the United States: 1998–2010. Obstet Gynecol 2015;126:258–65. CrossRef PubMed
- Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Mathews TJ. Births: Final data for 2015. Natl Vital Stat Rep 2017;66:1. PubMed
- Jones RK, Jerman J. Characteristics and circumstances of U.S. women who obtain very early and second-trimester abortions. PLoS One 2017;12:e0169969. CrossRef PubMed
- Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med 2016;374:843–52. CrossRef PubMed
- Dehlendorf C, Rodriguez MI, Levy K, Borrero S, Steinauer J. Disparities in family planning. Am J Obstet Gynecol 2010;202:214–20. CrossRef PubMed
- Pazol K, Robbins CL, Black LI, et al. Receipt of selected preventive health services for women and men of reproductive age—United States, 2011–2013. MMWR Surveill Summ 2017;66(No. SS-20). CrossRef PubMed
- Buehler JW, Schulz KF, Grimes DA, Hogue CJ. The risk of serious complications from induced abortion: do personal characteristics make a difference? Am J Obstet Gynecol 1985;153:14–20. CrossRef PubMed
- Ferris LE, McMain-Klein M, Colodny N, Fellows GF, Lamont J. Factors associated with immediate abortion complications. CMAJ 1996;154:1677–85. PubMed
- Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004;103:729–37. CrossRef PubMed
- Lichtenberg ES, Paul M; Society of Family Planning. Surgical abortion prior to 7 weeks of gestation. Contraception 2013;88:7–17. CrossRef PubMed
- Foster DG, Kimport K. Who seeks abortions at or after 20 weeks? Perspect Sex Reprod Health 2013;45:210–8. CrossRef PubMed
- Jones RK, Finer LB. Who has second-trimester abortions in the United States? Contraception 2012;85:544–51. CrossRef PubMed
- Kiley JW, Yee LM, Niemi CM, Feinglass JM, Simon MA. Delays in request for pregnancy termination: comparison of patients in the first and second trimesters. Contraception 2010;81:446–51. CrossRef PubMed
- Drey EA, Foster DG, Jackson RA, Lee SJ, Cardenas LH, Darney PD. Risk factors associated with presenting for abortion in the second trimester. Obstet Gynecol 2006;107:128–35. CrossRef PubMed
- Finer LB, Frohwirth LF, Dauphinee LA, Singh S, Moore AM. Timing of steps and reasons for delays in obtaining abortions in the United States. Contraception 2006;74:334–44. CrossRef PubMed
- Joyce TJ, Henshaw SK, Dennis A, Finer LB, Blanchard K. The impact of state mandatory counseling and waiting period laws on abortion: a literature review. New York, NY: Guttmacher Institute; 2009. https://www.guttmacher.org/report/impact-state-mandatory-counseling-and-waiting-period-laws-abortion-literature-review
- Kaunitz AM, Rovira EZ, Grimes DA, Schulz KF. Abortions that fail. Obstet Gynecol 1985;66:533–7. PubMed
- Creinin MD, Edwards J. Early abortion: surgical and medical options. Curr Probl Obstet Gynecol Fertil 1997;20:1–32.
- Edwards J, Carson SA. New technologies permit safe abortion at less than six weeks’ gestation and provide timely detection of ectopic gestation. Am J Obstet Gynecol 1997;176:1101–6. CrossRef PubMed
- Paul ME, Mitchell CM, Rogers AJ, Fox MC, Lackie EG. Early surgical abortion: efficacy and safety. Am J Obstet Gynecol 2002;187:407–11. CrossRef PubMed
- Baldwin MK, Bednarek PH, Russo J. Safety and effectiveness of medication and aspiration abortion before or during the sixth week of pregnancy: A retrospective multicenter study. Contraception 2020;102:13–7. CrossRef PubMed
- Nippita S, Paul M. Abortion. In: Hatcher RA, Nelson AL, Trussell J, et al, eds. Contraceptive technology, 21st ed. New York, NY: Ayer Company Publishers, Inc.; 2018:779–827.
- Kapp N, Baldwin MK, Rodriguez MI. Efficacy of medical abortion prior to 6 gestational weeks: a systematic review. Contraception 2018;97:90–9. CrossRef PubMed
- Kapp N, Eckersberger E, Lavelanet A, Rodriguez MI. Medical abortion in the late first trimester: a systematic review. Contraception 2019;99:77–86. CrossRef PubMed
- Jerman J, Frohwirth L, Kavanaugh ML, Blades N. Barriers to abortion care and their consequences for patients traveling for services: qualitative findings from two states. Perspect Sex Reprod Health 2017;49:95–102. CrossRef PubMed
- Klerman LV. The intendedness of pregnancy: a concept in transition. Matern Child Health J 2000;4:155–62. CrossRef PubMed
- Lifflander A, Gaydos LM, Hogue CJ. Circumstances of pregnancy: low income women in Georgia describe the difference between planned and unplanned pregnancies. Matern Child Health J 2007;11:81–9. CrossRef PubMed
- Sable MR, Wilkinson DS. Pregnancy intentions, pregnancy attitudes, and the use of prenatal care in Missouri. Matern Child Health J 1998;2:155–65. CrossRef PubMed
- Santelli J, Rochat R, Hatfield-Timajchy K, et al. ; Unintended Pregnancy Working Group. The measurement and meaning of unintended pregnancy. Perspect Sex Reprod Health 2003;35:94–101. CrossRef PubMed
- Santelli JS, Lindberg LD, Orr MG, Finer LB, Speizer I. Toward a multidimensional measure of pregnancy intentions: evidence from the United States. Stud Fam Plann 2009;40:87–100. CrossRef PubMed
- Trussell J, Vaughan B, Stanford J. Are all contraceptive failures unintended pregnancies? Evidence from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:246–7, 260. PubMed
- Ricketts S, Klingler G, Schwalberg R. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women. Perspect Sex Reprod Health 2014;46:125–32. CrossRef PubMed
- Peipert JF, Madden T, Allsworth JE, Secura GM. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol 2012;120:1291–7. CrossRef PubMed
- Kost K, Maddow-Zimet I, Arpaia A. Pregnancies, births and abortions among adolescents and young women in the United States, 2013: national and state trends by age, race and ethnicity. New York, NY: Guttmacher Institute; 2017. https://www.guttmacher.org/sites/default/files/report_pdf/us-adolescent-pregnancy-trends-2013.pdf
- Biggs MA, Rocca CH, Brindis CD, Hirsch H, Grossman D. Did increasing use of highly effective contraception contribute to declining abortions in Iowa? Contraception 2015;91:167–73. CrossRef PubMed
- Roth LP, Sanders JN, Simmons RG, Bullock H, Jacobson E, Turok DK. Changes in uptake and cost of long-acting reversible contraceptive devices following the introduction of a new low-cost levonorgestrel IUD in Utah’s Title X clinics: a retrospective review. Contraception 2018;98:63–8. CrossRef PubMed
- Finer LB, Henshaw SK. Abortion incidence and services in the United States in 2000. Perspect Sex Reprod Health 2003;35:6–15. CrossRef PubMed
- Henshaw SK. Abortion incidence and services in the United States, 1995–1996. Fam Plann Perspect 1998;30:263–70, 287. PubMed
- Jones RK, Zolna MR, Henshaw SK, Finer LB. Abortion in the United States: incidence and access to services, 2005. Perspect Sex Reprod Health 2008;40:6–16. CrossRef PubMed
- Quast T, Gonzalez F, Ziemba R. Abortion facility closings and abortion rates in Texas. Inquiry 2017;54:46958017700944. CrossRef PubMed
- Sanders JN, Conway H, Jacobson J, Torres L, Turok DK. The longest wait: examining the impact of Utah’s 72-hour waiting period for abortion. Womens Health Issues 2016;26:483–7. CrossRef PubMed
- Ely G, Polmanteer RSR, Caron A. Access to abortion services in Tennessee: does distance traveled and geographic location influence return for a second appointment as required by the mandatory waiting period policy? Health Soc Work 2019;44:13–21. CrossRef PubMed
- Dennis A, Henshaw SK, Joyce TJ, Finer LB, Blanchard K. The impact of laws requiring parental involvement for abortion: a literature review. New York, NY: Guttmacher Institute; 2009. https://www.guttmacher.org/report/impact-laws-requiring-parental-involvement-abortion-literature-review
- Ramesh S, Zimmerman L, Patel A. Impact of parental notification on Illinois minors seeking abortion. J Adolesc Health 2016;58:290–4. CrossRef PubMed
- Grossman D, Baum S, Fuentes L, et al. Change in abortion services after implementation of a restrictive law in Texas. Contraception 2014;90:496–501. CrossRef PubMed
- Joyce T. The supply-side economics of abortion. N Engl J Med 2011;365:1466–9. CrossRef PubMed
- Grossman D, White K, Hopkins K, Potter JE. Change in distance to nearest facility and abortion in Texas, 2012 to 2014. JAMA 2017;317:437–9. CrossRef PubMed
- White K, Baum SE, Hopkins K, Potter JE, Grossman D. Change in second-trimester abortion after implementation of a restrictive state law. Obstet Gynecol 2019;133:771–9. CrossRef PubMed
- Jones RK, Ingerick M, Jerman J. Differences in abortion service delivery in hostile, middle-ground, and supportive states in 2014. Womens Health Issues 2018;28:212–8. CrossRef PubMed
- Martinez GM, Chandra A, Abma JC, Jones J, Mosher WD. Fertility, contraception, and fatherhood: data on men and women from cycle 6 (2002) of the 2002 National Survey of Family Growth. Vital Health Stat 23 2006;23:1–142. PubMed
- Ventura SJ. Changing patterns of nonmarital childbearing in the United States. NCHS Data Brief 2009;18:1–8. PubMed
- Guttmacher Institute. A real-time look at the impact of the recession on women’s family planning and pregnancy decisions. New York, NY: Guttmacher Institute; 2009. https://www.guttmacher.org/report/real-time-look-impact-recession-womens-family-planning-and-pregnancy-decisions
- Kavanaugh ML, Jerman J. Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014. Contraception 2018;97:14–21. CrossRef PubMed
- Abma JC, Martinez GM. Sexual activity and contraceptive use among teenagers in the United States, 2011–2015. Natl Health Stat Report 2017;104:1–23. PubMed
- Kann L, McManus T, Harris WA, et al. Youth risk behavior surveillance—United States, 2015. MMWR Surveill Summ 2016;65(No. SS-6). PubMed
- Daniels K, Abma J. Current contraceptive status among women aged 15–49: United States, 2015–2017. NCHS Data Brief 2018;327:1–8.
- Lindberg LD, Santelli JS, Desai S. Changing patterns of contraceptive use and the decline in rates of pregnancy and birth among U.S. adolescents, 2007–2014. J Adolesc Health 2018;63:253–6. CrossRef PubMed
- Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol 2012;206:37.e1–6. CrossRef PubMed
- Cameron ST, Glasier A, Chen ZE, Johnstone A, Dunlop C, Heller R. Effect of contraception provided at termination of pregnancy and incidence of subsequent termination of pregnancy. BJOG 2012;119:1074–80. CrossRef PubMed
- Ames CM, Norman WV. Preventing repeat abortion in Canada: is the immediate insertion of intrauterine devices postabortion a cost-effective option associated with fewer repeat abortions? Contraception 2012;85:51–5. CrossRef PubMed
- Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008;78:143–8. CrossRef PubMed
- Qasba NT, Stutsman JW, Weaver GE, Jones KE, Daggy JK, Wilkinson TA. Informing policy change: a study of rapid repeat pregnancy in adolescents to increase access to immediate postpartum contraception. J Womens Health (Larchmt) 2020;29:815–8. CrossRef PubMed
- Lichtenstein Liljeblad K, Kopp Kallner H, Brynhildsen J. Risk of abortion within 1–2 years after childbirth in relation to contraceptive choice: a retrospective cohort study. Eur J Contracept Reprod Health Care 2020;25:141–6. CrossRef PubMed
- Harrison MS, Zucker R, Scarbro S, Sevick C, Sheeder J, Davidson AJ. Postpartum contraceptive use among Denver-based adolescents and young adults: association with subsequent repeat delivery. J Pediatr Adolesc Gynecol 2020;33:393–397.e1. CrossRef PubMed
- Goyal V, Canfield C, Aiken AR, Dermish A, Potter JE. Postabortion contraceptive use and continuation when long-acting reversible contraception is free. Obstet Gynecol 2017;129:655–62. CrossRef PubMed
- Gyllenberg FK, Saloranta TH, But A, Gissler M, Heikinheimo O. Induced abortion in a population entitled to free-of-charge long-acting reversible contraception. Obstet Gynecol 2018;132:1453–60. CrossRef PubMed
- Biggs MA, Taylor D, Upadhyay UD. Role of insurance coverage in contraceptive use after abortion. Obstet Gynecol 2017;130:1338–46. CrossRef PubMed
- Boulet SL, D’Angelo DV, Morrow B, et al. Contraceptive use among nonpregnant and postpartum women at risk for unintended pregnancy, and female high school students, in the context of Zika preparedness—United States, 2011–2013 and 2015. MMWR Morb Mortal Wkly Rep 2016;65:780–7. CrossRef PubMed
- Kumar N, Brown JD. Access barriers to long-acting reversible contraceptives for adolescents. J Adolesc Health 2016;59:248–53. CrossRef PubMed
- Parks C, Peipert JF. Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC). Am J Obstet Gynecol 2016;214:681–8. CrossRef PubMed
- Klein DA, Berry-Bibee EN, Keglovitz Baker K, Malcolm NM, Rollison JM, Frederiksen BN. Providing quality family planning services to LGBTQIA individuals: a systematic review. Contraception 2018;97:378–91. CrossRef PubMed
FIGURE. Number, rate,* and ratio† of abortions performed, by year — selected reporting areas,§ United States, 2009–2018
* Number of abortions per 1,000 women aged 15–44 years.
† Number of abortions per 1,000 live births.
§ Data are for 48 reporting areas; excludes California, District of Columbia, Maryland, and New Hampshire.
Suggested citation for this article: Kortsmit K, Jatlaoui TC, Mandel MG, et al. Abortion Surveillance — United States, 2018. MMWR Surveill Summ 2020;69(No. SS-7):1–29. DOI: http://dx.doi.org/10.15585/mmwr.ss6907a1.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.